BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7686266)

  • 21. Statistical calculation of detection limits for DNA adducts using the 32P-postlabeling assay with a standard addition procedure.
    Lutz WK; Lutz U; Gaylor DW
    Mutat Res; 2002 Jul; 518(2):195-203. PubMed ID: 12113770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Storage phosphor imaging technique for detection and quantitation of DNA adducts measured by the 32P-postlabeling assay.
    Reichert WL; Stein JE; French B; Goodwin P; Varanasi U
    Carcinogenesis; 1992 Aug; 13(8):1475-9. PubMed ID: 1499099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 32P-postlabeling assay for DNA adducts.
    Phillips DH; Arlt VM
    Nat Protoc; 2007; 2(11):2772-81. PubMed ID: 18007613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 32P-Postlabeling of N-(deoxyguanosin-8-yl)arylamine adducts: a comparative study of labeling efficiencies.
    Mourato LL; Beland FA; Marques MM
    Chem Res Toxicol; 1999 Jul; 12(7):661-9. PubMed ID: 10409407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
    Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
    Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
    Gupta RC
    Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 32P-postlabeling analysis of DNA adducts.
    Phillips DH; Hewer A; Arlt VM
    Methods Mol Biol; 2005; 291():3-12. PubMed ID: 15502206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous and endogenous DNA modifications as monitored by 32P-postlabeling: relationships to cancer and aging.
    Randerath K; Li D; Nath R; Randerath E
    Exp Gerontol; 1992; 27(5-6):533-49. PubMed ID: 1426086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection and identification of benzo[a]pyrene-DNA adducts by [35S]phosphorothioate labeling and HPLC.
    Lau HH; Baird WM
    Carcinogenesis; 1991 May; 12(5):885-93. PubMed ID: 2029754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pH of the T4 polynucleotide kinase reaction on the 32P-postlabeling assay of DNA adducts.
    Lee CK; Brown BG; Bombick BR; Doolittle DJ
    Anal Biochem; 1995 May; 227(1):156-61. PubMed ID: 7668376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 32P-Postlabeling analysis of DNA adducts of styrene 7,8-oxide at the O6-position of guanine.
    Otteneder M; Eder E; Lutz WK
    Chem Res Toxicol; 1999 Jan; 12(1):93-9. PubMed ID: 9894023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 32P-postlabeling analysis of adducts formed from 1-phenylazo-2-hydroxynaphthalene (Sudan I, Solvent Yellow 14) with DNA and homopolydeoxyribonucleotides.
    Stiborová M; Frei E; Schmeiser HH; Wiessler M
    Carcinogenesis; 1992 Jul; 13(7):1221-5. PubMed ID: 1638690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts.
    Levy GN; Weber WW
    Anal Biochem; 1988 Nov; 174(2):381-92. PubMed ID: 3239743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
    Wohlin P; Zeisig M; Gustafsson JA; Möller L
    Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx- and PhIP-treated monkeys.
    Snyderwine EG; Davis CD; Nouso K; Roller PP; Schut HA
    Carcinogenesis; 1993 Jul; 14(7):1389-95. PubMed ID: 8330355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 32P-Postlabeling/polyacrylamide gel electrophoresis analysis: application to the detection of DNA adducts.
    Terashima I; Suzuki N; Shibutani S
    Chem Res Toxicol; 2002 Mar; 15(3):305-11. PubMed ID: 11896676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures.
    Gupta RC; Earley K
    Carcinogenesis; 1988 Sep; 9(9):1687-93. PubMed ID: 3409474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative aspects of 32P-postlabeling.
    Hemminki K; Szyfter K; Vodicka P; Koivisto P; Mustonen R; Reunanen A
    Prog Clin Biol Res; 1991; 372():219-28. PubMed ID: 1956920
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantitative and kinetic examination of 32P-postlabeling of etheno-substituted nucleotides.
    Szyfter K; Hemminki K; Crane AE; Watson WP
    Chem Biol Interact; 1991; 80(1):99-107. PubMed ID: 1913981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
    Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
    Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.